Turkish Journal of Nephrology
Case Report

Uncontrolled Hypertension and Hyperkalemia Related to Low Dose Daily Acetylsalicylic Acid Therapy in a Patient with Coronary Artery Disease: A Case Report

1.

Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Zonguldak, Turkey

2.

Zonguldak Atatürk State Hospital, Department of Nephrology, Zonguldak, Turkey

3.

Bülent Ecevit University Faculty of Medicine, Department of Radiology, Zonguldak, Turkey

4.

Bülent Ecevit University Faculty of Medicine, Department of Nephrology, Zonguldak, Turkey

Turkish J Nephrol 2018; 27: 204-206
DOI: 10.5262/tndt.2018.2662
Read: 1421 Downloads: 769 Published: 31 January 2019

Acetylsalicylic acid (ASA) is a member of the non-steroidal anti-inflammatory drugs (NSAIDs). Thus, it can cause side effects such as fluid, electrolyte and acid-base imbalances through the enzyme cyclooxygenases (COX 1-2). Despite the wide use of ASA and its general good safety profile, sensitivity to ASA should be kept in mind. Here, we reported a patient who presented with hypertension and hyperkalemia after low dose ASA treatment.

Files
EISSN 2667-4440